United Therapeutics (UTHR) Total Liabilities (2009 - 2026)
United Therapeutics (UTHR) reported Total Liabilities of $813.1 million for Q1 2026, down 13.2% on a YoY basis from $936.7 million in Q1 2025, and up 3.74% sequentially from $783.8 million in Q4 2025.
United Therapeutics (UTHR) Total Liabilities (2009 - 2026) Analysis & Trends
United Therapeutics (UTHR) has 18 years of Total Liabilities data on file, last reported at $813.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 13.2% year-over-year to $813.1 million; the trailing twelve-month figure through Mar 2026 stood at $813.1 million (down 13.2% YoY), and the FY2025 full-year result was $783.8 million, down 14.8% from the prior year.
- Total Liabilities advanced to $813.1 million in Q1 2026, from $783.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.3 billion in Q3 2023 to a low of $734.4 million in Q2 2025.
- A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities gained 7.55% in 2023 and fell 28.42% in 2025, its largest moves.
- Tracing UTHR's Total Liabilities over 5 years: stood at $1.2 billion in 2022, then fell by 5.26% to $1.2 billion in 2023, then dropped by 22.18% to $920.0 million in 2024, then fell by 14.8% to $783.8 million in 2025, then advanced by 3.74% to $813.1 million in 2026.
- Business Quant data shows UTHR's Total Liabilities at $813.1 million in Q1 2026, $783.8 million in Q4 2025, and $760.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 634.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 813.10 Mn |
| Dec 31, 2025 | 783.80 Mn |
| Sep 30, 2025 | 760.90 Mn |
| Jun 30, 2025 | 734.40 Mn |
| Mar 31, 2025 | 936.70 Mn |
| Dec 31, 2024 | 920.00 Mn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 1.27 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.22 Bn |
| Jun 30, 2022 | 1.22 Bn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.22 Bn |
| Jun 30, 2021 | 1.21 Bn |